Resources for each step of the treatment journey with
AUSTEDO

Teva is committed to supporting you, your Huntington’s disease (HD) chorea patients, and their carepartners.

Downloadable resources for prescribers

Prescription and Service Request Form (PSRF)

Fill out this form to enroll your patient in Teva’s Shared Solutions®.

Appeals Letter Template

Use this template to write an appeals letter, which payers may need to appeal a denial of coverage for AUSTEDO.

Letter of Medical Necessity Template

Use this template to write a letter to establish medical necessity, which payers may require for treatment with AUSTEDO.


Downloadable resources for your patients with HD chorea

Treatment Tracking Guide

A useful resource for patients as they begin their treatment journey. Patients and their carepartners can use this tracking tool to record when they take AUSTEDO, as well as any changes in their HD chorea.

Patient Brochure for AUSTEDO

This brochure provides answers to important questions your patients with HD chorea and their carepartners may have when starting treatment with AUSTEDO.

Shared Solutions® Patient Brochure

This brochure provides an overview of patient support services offered through Shared Solutions, including help with access, affordability, and adherence.

Blue video icon.

Videos to help you support your patients with HD chorea

play button

Mechanism of Action

VMAT2 inhibition can help regulate dopamine function.1

play button

The Impact of HD Chorea

Eileen discusses how her life, and in particular—her work, has been affected by HD chorea.

VMAT2, vesicular monoamine transporter 2.

REFERENCE: 1. Solmi M, Pigato G, Kane JM, Correll CU. Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2018;12:1215-1238.